COLLEGIUM PHARMACEUTICAL, INC

COLL

COLLEGIUM PHARMACEUTICAL, INC

COLL

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-05-18Shares Purchased (TTM):0Shares Sold (TTM):191,104

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:36,820,342Shares Outstanding:32,087,472Institutional Ownership Pct.:114.75%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	129	269	231	150	117	96	71	39	173	229	239	259
Marketable Securities Current	0	153	155	136	105	102	92	81	99	89	72	46
Accounts Receivable Net Current	285	229	211	234	213	229	229	228	184	175	180	182
Inventory Net	113	43	41	38	38	37	36	38	28	31	32	34
Prepaid Expense And Other Assets Current	60	33	33	36	56	44	30	32	27	15	15	17
Restricted Cash Current	20	20	20	20	20	20	25	25	-	-	-	-
Assets Current	608	746	691	614	549	528	482	444	510	539	538	537
Property Plant And Equipment Net	11	12	12	12	13	14	14	15	15	15	16	17
Operating Lease Right Of Use Asset	4	4	4	4	5	6	6	6	6	6	6	6
Intangible Assets Net Excluding Goodwill	1,186	614	670	725	780	836	891	947	353	387	422	456
Restricted Cash And Cash Equivalents Noncurrent	-	-	-	-	-	-	-	-	1	1	1	1
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	-	-	1	-
Deferred Income Tax Assets Net	121	114	113	102	92	92	98	73	34	31	26	26
Other Assets Noncurrent	15	16	20	2	4	5	8	4	1	1	1	1
Goodwill	190	146	146	146	148	151	162	146	134	134	134	134
Assets	2,136	1,652	1,657	1,607	1,593	1,631	1,664	1,635	1,053	1,114	1,143	1,178
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	9	7	11	8	11	18	4	3	2	6	9	4
Accrued Liabilities Current	71	58	62	51	59	54	72	48	39	38	38	32
Loans Payable Current	55	33	29	65	65	65	65	65	183	183	183	183
Operating Lease Liability Current	2	1	1	1	1	1	1	1	1	1	1	1
Business Combination Contingent Consideration Liab…	16	18	18	0	0	25	29	29	-	-	-	-
Contract With Customer Liability Current	1	1	1	1	-	-	0	-	-	-	-	-
Liabilities Current	590	435	440	453	465	487	510	459	462	446	458	465
Long Term Loans Payable	798	532	542	506	521	536	551	566	133	177	222	266
Convertible Long Term Notes Payable	239	238	238	238	238	237	237	237	237	262	262	262
Operating Lease Liability Noncurrent	3	4	4	5	5	5	6	6	6	6	6	6
Contract With Customer Liability Noncurrent	9	9	9	9	10	10	10	10	-	-	-	-
Business Combination Contingent Consideration Liab…	-	-	0	-	-	0	1	4	-	-	-	-
Liabilities	1,824	1,340	1,355	1,333	1,360	1,397	1,435	1,401	837	892	948	999
Stockholders Equity
Preferred Stock Value	0	0	0	-	-	-	0	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	636	622	625	615	599	593	590	583	568	565	566	546
Treasury Stock Common Value	-223	-223	-223	-223	-218	-198	-198	-172	-165	-137	-137	-102
Accumulated Other Comprehensive Income Loss Net Of…	0	-0	0	0	0	0	0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-102	-87	-101	-118	-150	-162	-164	-177	-186	-205	-233	-265
Stockholders Equity	312	312	302	275	232	234	229	234	217	222	195	179
Liabilities And Stockholders Equity	2,136	1,652	1,657	1,607	1,593	1,631	1,664	1,635	1,053	1,114	1,143	1,178
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	42	41	41	41	40	40	40	40	40	39	38	38
Shares Outstanding	32	32	32	32	32	32	31	32	32	33	32	33
Treasury Stock Common Shares	9	9	9	9	9	8	8	7	7	6	6	5

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-14.54%	-6.97%	-10.50%	-	-	-	-	-	-	-	-	-
2025	6.86%	9.75%	16.54%	17.79%	4.46%	7.16%	14.81%	22.58%	11.90%	-19.86%	-22.18%	-23.61%
2024	-12.47%	-14.95%	-4.70%	8.89%	8.32%	-1.76%	-12.13%	-16.13%	-6.11%	5.74%	-4.96%	6.37%
2023	-	-	-	-	-	-	18.08%	41.97%	53.04%	19.14%	8.84%	-3.99%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.03	1.71	1.57	1.36	1.18	1.08	0.95	0.97	1.11	1.21	1.17	1.16
Quick Ratio	0.74	1.54	1.40	1.19	0.98	0.92	0.82	0.81	0.99	1.10	1.07	1.05
Working Capital	18.15M	310.70M	251.38M	160.94M	84.60M	40.84M	-27.25M	-15.62M	48.48M	92.82M	79.69M	72.47M
Leverage & Debt
Debt to Equity	5.85	4.29	4.49	4.85	5.86	5.96	6.27	5.98	3.86	4.02	4.85	5.58
Interest Coverage TTM	2.06	2.44	2.18	1.83	1.58	1.84	2.30	2.74	2.79	2.42	2.00	1.38
Debt Ratio	0.85	0.81	0.82	0.83	0.85	0.86	0.86	0.86	0.79	0.80	0.83	0.85
Efficiency & Turnover
Asset Turnover TTM	0.43	0.49	0.47	0.47	0.53	0.48	0.45	0.43	0.51	0.49	0.49	0.46
Days Sales Outstanding TTM	112.48	104.84	102.84	111.47	102.45	110.83	117.94	124.96	111.19	113.90	116.77	125.95
Receivables Turnover TTM	3.25	3.48	3.55	3.27	3.56	3.29	3.09	2.92	3.28	3.20	3.13	2.90
Per Share Metrics
Diluted EPS TTM	1.48	1.87	1.58	1.48	0.93	1.34	1.71	2.21	2.47	2.25	1.15	0.21
Free Cash Flow Per Share TTM	10.11	10.28	10.33	9.16	6.34	6.18	6.30	5.97	8.50	9.53	8.13	7.90
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	60.02%	60.68%	59.35%	57.22%	56.69%	57.69%	59.76%	62.36%	61.94%	60.01%	57.55%	51.46%
Operating Profit Margin TTM	19.48%	23.71%	23.01%	20.74%	18.35%	21.39%	26.91%	32.29%	35.32%	33.83%	29.46%	21.41%
Net Profit Margin TTM	5.93%	9.41%	8.05%	7.72%	5.13%	6.61%	10.96%	14.78%	17.32%	16.46%	8.50%	1.65%
Growth Metrics
Net Revenue Growth (1Y)	14.31%	19.88%	23.62%	26.34%	22.61%	17.17%	11.41%	9.62%	7.39%	8.00%	22.17%	51.14%
Net Income Growth (1Y)	32.10%	70.75%	-9.13%	-34.03%	-63.69%	-52.95%	43.68%	882.63%	-995.02%	-417.77%	-292.60%	-83.21%
EPS Growth (1Y)	29.46%	69.19%	-7.51%	-32.60%	-62.98%	-52.16%	50.21%	927.86%	-1,055.43%	-437.36%	-293.11%	-83.06%
Valuation Metrics
P/E TTM	24.52	14.16	23.35	18.90	25.93	21.62	13.36	14.07	10.45	13.45	21.57	83.65
P/B TTM	3.77	3.40	4.87	4.02	4.05	4.05	4.04	5.32	4.82	5.65	5.31	4.22
P/S TTM	1.45	1.33	1.88	1.46	1.33	1.43	1.46	2.08	1.81	2.21	1.83	1.38
Market Cap	1.18B	1.06B	1.47B	1.10B	940.64M	949.04M	924.65M	1.25B	1.04B	1.25B	1.04B	754.18M
Enterprise Value	1.32B	1.04B	1.48B	1.24B	1.10B	1.13B	1.13B	1.51B	1.29B	1.47B	1.24B	939.76M
Calculated Values
Free Cash Flow TTM	328.28M	329.83M	327.58M	289.30M	201.81M	196.56M	203.33M	192.43M	275.62M	308.16M	274.29M	266.50M
Net Debt	143.36M	-18.46M	15.06M	131.53M	164.02M	184.92M	205.14M	262.53M	246.04M	216.10M	205.46M	185.58M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-18Sale

Owner: Freund, John Gordon

Title: -

Shares: 20

Price/Share: $34.05

Value: $681.00

Shares Owned: 83,952

Relationship: Director

Ownership: Direct

2026-05-15Sale

Owner: Freund, John Gordon

Title: -

Shares: 4,127

Price/Share: $34.54

Value: $142,546.58

Shares Owned: 83,972

Relationship: Director

Ownership: Direct

2026-05-13Sale

Owner: Lurker, Nancy

Title: -

Shares: 4,500

Price/Share: $35.97

Value: $161,865.00

Shares Owned: 18,017

Relationship: Director

Ownership: Direct

2026-05-11Sale

Owner: Bohlin, Garen G

Title: -

Shares: 8,700

Price/Share: $37.18

Value: $323,466.00

Shares Owned: 62,259

Relationship: Director

Ownership: Direct

2026-03-18Sale

Owner: Dieter, David

Title: EVP & General Counsel

Shares: 13,976

Price/Share: $34.92

Value: $488,041.92

Shares Owned: 77,071

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-18	Freund, John Gordon	Director	-	Direct	Sale	20	34.05	$681.00	83,952	4
2026-05-15	Freund, John Gordon	Director	-	Direct	Sale	4,127	34.54	$142,546.58	83,972	4
2026-05-13	Lurker, Nancy	Director	-	Direct	Sale	4,500	35.97	$161,865.00	18,017	4
2026-05-11	Bohlin, Garen G	Director	-	Direct	Sale	8,700	37.18	$323,466.00	62,259	4
2026-03-18	Dieter, David	Officer	EVP & General Counsel	Direct	Sale	13,976	34.92	$488,041.92	77,071	4
2026-03-09	Dieter, David	Officer	EVP & General Counsel	Direct	Sale	6,224	36.65	$228,109.60	91,047	4
2026-03-03	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	49,976	40.67	$2,032,523.92	71,770	4
2025-12-08	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	17,600	48.28	$849,728.00	103,613	4
2025-12-05	Balice-Gordon, Rita J.	Director	-	Direct	Sale	3,650	47.03	$171,659.50	52,629	4
2025-11-12	Fallon, John A.	Director	-	Direct	Sale	34,853	47.21	$1,645,410.13	64,634	4
2025-11-06	Tupper, Colleen	Officer	EVP & Chief Financial Officer	Direct	Sale	30,000	40.83	$1,224,900.00	126,667	4
2025-08-29	Smith, Thomas B	Officer	EVP and Chief Medical Officer	Direct	Sale	17,478	38.42	$671,504.76	70,264	4
2025-08-18	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	16,389	38.21	$626,223.69	103,613	4
2025-08-15	Santini, Gino	Director	-	Direct	Sale	5,405	37.19	$201,011.95	95,042	4
2025-08-13	Rubric, Capital Managemen…	TenPercentOwner	-	Indirect	Sale	25,000	37.85	$946,250.00	3,132,743	4
2025-08-13	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	4,861	38.03	$184,863.83	103,613	4
2025-08-08	Freund, John Gordon	Director	-	Indirect	Sale	11,659	34.36	$400,603.24	23,129	4
2025-06-09	Freund, John Gordon	Director	-	Direct	Sale	6,601	30.62	$202,122.62	70,658	4
2025-03-21	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	18,881	30.03	$566,996.43	103,613	4
2025-03-21	Tupper, Colleen	Officer	EVP & Chief Financial Officer	Direct	Sale	6,396	30.03	$192,071.88	156,667	4
2025-03-14	Tupper, Colleen	Officer	EVP & Chief Financial Officer	Direct	Sale	977	30.00	$29,310.00	164,269	4
2025-03-14	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	2,255	30.00	$67,650.00	124,421	4
2025-03-11	Tupper, Colleen	Officer	EVP & Chief Financial Officer	Direct	Sale	10,445	30.01	$313,454.45	165,246	4
2025-03-11	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	15,387	30.00	$461,610.00	126,676	4/A
2025-03-07	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	2,348	30.00	$70,440.00	142,063	4
2025-03-07	Tupper, Colleen	Officer	EVP & Chief Financial Officer	Direct	Sale	1,504	30.00	$45,120.00	175,691	4
2025-03-06	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	15,387	30.00	$461,610.00	126,676	4
2025-03-06	Kuhlmann, Shirley R.	Officer	EVP and General Counsel	Direct	Sale	26,067	28.50	$742,909.50	108,137	4
2025-01-10	Kuhlmann, Shirley R.	Officer	EVP and General Counsel	Direct	Sale	27,500	33.25	$914,375.00	119,184	4
2024-09-13	Smith, Thomas B	Officer	EVP and Chief Medical Officer	Direct	Sale	9,593	36.62	$351,295.66	53,816	4
2024-09-06	Kuhlmann, Shirley R.	Officer	EVP and General Counsel	Direct	Sale	977	37.46	$36,598.42	119,184	4
2024-06-03	Kuhlmann, Shirley R.	Officer	EVP and General Counsel	Direct	Sale	25,000	32.88	$822,000.00	139,409	4
2024-05-28	Tupper, Colleen	Officer	EVP & Chief Financial Officer	Direct	Sale	19,710	34.21	$674,279.10	130,845	4
2024-05-24	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	56,807	33.98	$1,930,301.86	105,902	4
2024-05-14	Bohlin, Garen G	Director	-	Direct	Sale	28,985	32.30	$936,215.50	44,775	4
2024-02-29	Smith, Thomas B	Officer	EVP and Chief Medical Officer	Direct	Sale	995	36.76	$36,576.20	63,409	4
2024-02-26	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	10,000	36.76	$367,600.00	138,918	4
2024-01-16	Dreyer, Scott	Officer	EVP & Chief Commercial Officer	Direct	Sale	23,560	32.28	$760,516.80	111,322	4
2023-12-21	Ciaffoni, Joseph	Director,Officer	President and CEO	Direct	Sale	4,357	30.38	$132,365.66	275,000	4
2023-12-20	Ciaffoni, Joseph	Director,Officer	President and CEO	Direct	Sale	26,454	30.40	$804,201.60	275,000	4
2023-11-27	Kuhlmann, Shirley R.	Officer	EVP and General Counsel	Direct	Sale	25,600	25.78	$659,968.00	119,518	4
2023-06-26	Kuhlmann, Shirley R.	Officer	EVP and General Counsel	Direct	Sale	17,984	22.09	$397,266.56	119,518	4
2023-06-02	Ciaffoni, Joseph	Director,Officer	President and CEO	Direct	Sale	31,272	21.92	$685,482.24	275,000	4
2023-05-31	Ciaffoni, Joseph	Director,Officer	President and CEO	Direct	Sale	31,272	21.87	$683,918.64	337,544	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

114.75%

Inst. Shares: 36,820,342

Shares Outstanding: 32,087,472

2025-12-31

113.62%

Inst. Shares: 36,025,170

Shares Outstanding: 31,706,429

2025-09-30

114.72%

Inst. Shares: 36,217,601

Shares Outstanding: 31,571,410

2025-06-30

109.80%

Inst. Shares: 34,929,272

Shares Outstanding: 31,810,612

2025-03-31

111.78%

Inst. Shares: 35,538,868

Shares Outstanding: 31,793,739

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	36,820,342	32,087,472	114.75%
2025-12-31	36,025,170	31,706,429	113.62%
2025-09-30	36,217,601	31,571,410	114.72%
2025-06-30	34,929,272	31,810,612	109.80%
2025-03-31	35,538,868	31,793,739	111.78%
2024-12-31	36,243,680	32,273,850	112.30%
2024-09-30	37,392,963	32,259,468	115.91%
2024-06-30	38,478,418	32,433,025	118.64%
2024-03-31	35,591,831	32,326,589	110.10%
2023-12-31	35,132,083	33,741,213	104.12%
2023-09-30	34,937,098	33,744,209	103.54%
2023-06-30	35,514,023	34,622,284	102.58%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

COLLEGIUM PHARMACEUTICAL, INC (COLL) — SEC Financial Statements & Analysis

COLLEGIUM PHARMACEUTICAL, INC (COLL) is a pharmaceutical preparations company, incorporated in VA. COLLEGIUM PHARMACEUTICAL, INC trades on Nasdaq as: COLL. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), COLLEGIUM PHARMACEUTICAL, INC reported a 14.31% year-over-year revenue growth, a Gross Profit Margin of 60.02% (TTM), a Debt-to-Equity ratio of 5.85x, a Price-to-Sales (P/S) ratio of 1.45x (TTM), a Price-to-Book (P/B) ratio of 3.77x (TTM), at a market cap of $1.18B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 14.31%
Gross Profit Margin TTM: 60.02%
Debt To Equity: 5.85x
P/S TTM: 1.45x
P/B TTM: 3.77x
Market Cap: $1.18B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is COLLEGIUM PHARMACEUTICAL, INC in?

COLLEGIUM PHARMACEUTICAL, INC (COLL) operates in the Pharmaceutical Preparations industry.

What is COLL's market cap?

COLLEGIUM PHARMACEUTICAL, INC (COLL) has a market capitalization of $1.18B as of 2026-06-30.

What is COLL's P/E ratio?

COLLEGIUM PHARMACEUTICAL, INC (COLL)'s trailing twelve month P/E ratio is 24.52x as of 2026-06-30.

What exchange does COLL trade on?

COLLEGIUM PHARMACEUTICAL, INC (COLL) trades on the Nasdaq.

Where is COLLEGIUM PHARMACEUTICAL, INC incorporated?

COLLEGIUM PHARMACEUTICAL, INC is incorporated in VA.